The current status of the transition to the MDR and IVDR regulations by Giuliana Miglierini As the term to apply for the certification of medical devices and in vitro diagnostics…
The proposals of the EU Commission for the revision of the IP legislation By Giuliana Miglierini In parallel to the new pharmaceutical legislation, on 27 April 2023 the EU Commission issued…
MDCG, a position paper on the capacity of notified bodies by Giuliana Miglierini The lack of a suitable capacity of notified bodies (NBs) is one of the main…